Over-the-Counter Monograph Drug User Fee Amendments

# Over-the-Counter Monograph Drug User Fee Amendments (S 2292) **What the Bill Would Do:** This bill would establish or modify user fees for over-the-counter (OTC) drugs regulated under the FDA's "monograph" system. OTC monographs are pre-approved categories of common medications (like pain relievers, cold medicines, and antacids) that manufacturers can produce without submitting individual applications. The bill would require companies that make these drugs to pay fees to support FDA oversight and safety reviews of these products. **Who It Affects and Key Provisions:** The bill primarily affects manufacturers of OTC monograph drugs and, indirectly, consumers who use these common medications.

The revenues generated from user fees would fund FDA activities related to regulating and monitoring OTC drug safety and quality. This is similar to user fee programs already in place for prescription drugs and medical devices, where industry helps pay for regulatory review costs. **Current Status:** As of now, the bill is in committee and has not yet been voted on by the full Senate. This means it's still in the early legislative stage and hasn't advanced to broader congressional debate.